CLINICAL TRIAL CONSENTS:

ACTG Studies

 

CFAR Query Request Form

Pre-Screen IC V2 4/12/16 *EFFECTIVE 4/18/16

Cryopreservation IC V9 1/25/10 *EFFECTIVE 6/1/16

A5128 V4 IC V8 4/2/13 *EFFECTIVE 10/20/15

HPTN 069/A5305 V3 IC V8 9/29/14 *EFFECTIVE 10/15/14

A5308 V1 IC V4 5/2/14 *EFFECTIVE 8/21/14

A5314 V2 IC V8 12/15/15 *EFFECTIVE 12/22/15

A5315 V2 IC V9 12/2/15 *EFFECTIVE 12/8/15

A5320 V2 IC V4 2/20/15 *EFFECTIVE 1/25/16

A5321 V2 IC V7 6/7/16 *EFFECTIVE 7/25/16

A5322 V2 IC V5 2/25/16 *EFFECTIVE 3/7/16

A5327 V2 Cohort 2 IC V1 7/15/15 *EFFECTIVE 3/14/16

A5329 V1 IC V3 6/7/16 *EFFECTIVE 7/21/16

A5332 V3 IC V6 2/4/16 *EFFECTIVE 3/10/16

A5333s V3 IC V3 2/4/16 *EFFECTIVE 3/10/16

A5335s V1 IC V2 3/22/16 *EFFECTIVE 4/1/16

A5336 V2 IC V2 7/5/16 *EFFECTIVE 7/20/16

A5340 V2 IC V4 5/18/16 *EFFECTIVE 6/14/16

A5341s V1 IC V2 1/13/16 *EFFECTIVE 3/2/16

A5346 V1 IC V2 12/4/15 *EFFECTIVE 1/13/16

A5350 V1 IC V3 3/15/16 *EFFECTIVE 3/31//16

A5353 V1 IC V2 10/21/15 *EFFECTIVE 12/10/15

Cocaine Use PET Scan IC V3 2/25/14 *EFFECTIVE 12/16/15

Promise V2 IC V6 3/28/13 *EFFECTIVE 5/2/13

Promise V2Pregnancy IC V4 5/9/13 *EFFECTIVE 11/24/14

Promise V2 stored specimen IC V3 11/5/12 *EFFECTIVE 12/20/12

Industry Studies

Bavarian Nordic POX-MVA-037 IC V4 12/5/14 *EFFECTIVE 3/2/15

BMS AI438047 IC V3 6/30/15 *EFFECTIVE 11/2/15

BMS AI438047 PG IC V1 1/26/15 *EFFECTIVE 11/2/15

BMS AI438047 Addendum IC V1 5/27/16 * EFFECTIVE 6/21/16

BMS AI438047 Letter 5/27/16 *EFFECTIVE 6/21/16

EBOV-001 IC V2 4/22/15 *EFFECTIVE 5/20/15

Emend IV IC V2 3/17/14 *EFFECTIVE 2/9/15

EV Biomarkers - Dr. Mohler IC V2 3/16/16 *EFFECTIVE 6/21/16

Gilead US248-0122 IC4 8/12/14 *EFFECTIVE 7/25/16

Gilead US248-0123 IC4 8/12/14 *EFFECTIVE 11/13/14

Gilead US292-0104 IC7 1/23/15 *EFFECTIVE 3/5/15

Gilead US292-0109 IC6 3/5/15 *EFFECTIVE 4/7/15

Gilead US292-0109 FIGHT DEXA IC2 5/15/13 *EFFECTIVE 7/17/13

Gilead US292-0111 IC5 1/24/15 *EFFECTIVE 3/5/15

Gilead US292-0112 IC8 11/5/15 *EFFECTIVE 12/14/15

Gilead US292-0112 PK/PD IC1 8/20/13 *EFFECTIVE 10/7/13

Gilead US292-0119 IC5 1/30/15 *EFFECTIVE 3/5/15

Gilead US292-0119 PK IC3 10/30/13 *EFFECTIVE 11/20/13

Gilead US366-1160 IC 6/16/16 *EFFECTIVE 6/20/16

Gilead US366-1216 IC 6/16/16 *EFFECTIVE 6/20/16

Gilead US366-1216 Dexa IC 5/13/16 *EFFECTIVE 6/20/16

Gilead US366-1992 IC 3/29/16 *EFFECTIVE 3/30/16

Gilead US366-1992 Pregnancy IC 3/29/16 *EFFECTIVE 3/30/16

Gilead US380-1489 IC 2/26/16 *EFFECTIVE 3/2/16

Gilead US380-1489 Triumeq Insert *EFFECTIVE 4/22/16

Gilead US380-1489 Pregnancy IC 11/3/15 *EFFECTIVE 12/9/15

Gilead US380-1490 IC 2/26/16 *EFFECTIVE 3/2/16

Gilead US380-1490 Tivicay Insert *EFFECTIVE 4/22/16

Gilead US380-1490 Pregnancy IC 11/3/15 *EFFECTIVE 12/10/15

HVTN 104 IC V2 4/3/15 *EFFECTIVE 4/13/15

IRC003 V7 IC V4 2/3/16 *EFFECTIVE 3/14/16

IRC005 V1 IC V4 2/1/16 *EFFECTIVE 2/8/16

Jean Boyer Venipuncture Study IC V5 5/24/12 *EFFECTIVE 1/14/15

Leukapheresis - Reservoirs IC V2 12/1/15 *EFFECTIVE 5/25/16

Merck MK-1436A-021 IC 10/20/15 *EFFECTIVE 10/22/15

Merck MK-1436A-021 FBR IC 6/16/15 *EFFECTIVE 6/22/15

Merck MK-1436A-024 IC 6/13/16 *EFFECTIVE 6/15/16

Merck MK-1436A-024 ext IC 5/26/16 *EFFECTIVE 6/15/16

Merck MK-1436A-024 FBR IC 6/16/15 *EFFECTIVE 6/22/15

Pfizer Poem A4001067 IC V5 3/21/12 *EFFECTIVE 2/28/13

Sangamo (znf) LTFU V4 1/8/14 *EFFECTIVE 10/12/15

Sangamo II (m-rna) LTFU V2 3/29/16 *EFFECTIVE 4/18/16

Sangamo SB-728mR Cohort 1 V11 9/10/15 *EFFECTIVE 11/2/15

Sangamo SB-728mR Cohort 2/3 V2 2/9/16 *EFFECTIVE 7/25/16

Statin HAND Study IC V2 8/22/13 *EFFECTIVE 2/16/15

Virxsys/Adapt LTFU 3/30/12 - *EFFECTIVE 7/7/16

 
 


About Penn Medicine   Contact Us   Site Map   Privacy Statement   Legal Disclaimer   Terms of Use

Penn Medicine, Philadelphia, PA 800-789-PENN © 2015, The Trustees of the University of Pennsylvania